Iterum Therapeutics (ITRM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Iterum Therapeutics

    NASDAQ: ITRM · Real-Time Price · USD
    0.68
    0.05 (7.59%)
    At close: Sep 05, 2025, 3:59 PM
    0.70
    2.90%
    After-hours: Sep 05, 2025, 07:43 PM EDT

    Iterum Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 254K 1.75M 1.8M n/a
    Gross Profit
    		 -254K -1.75M -1.8M -2.1M
    Operating Income
    		 -18.7M -47.47M -30.38M -24.54M
    Interest Income
    		 n/a 1.43M 2.36K 4.53K
    Pretax Income
    		 -24.53M -37.76M -44.13M -90.86M
    Net Income
    		 -24.77M -38.37M -44.43M -91.56M
    Selling & General & Admin
    		 7.98M 7.48M 12.77M 13.82M
    Research & Development
    		 10.46M 39.99M 17.62M 10.71M
    Other Expenses
    		 n/a n/a -16.85M 195K
    Operating Expenses
    		 18.44M 47.47M 30.38M 24.54M
    Interest Expense
    		 n/a 1.43M 2.36M 5.55M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 18.7M 47.47M 30.38M 24.54M
    Income Tax Expense
    		 240K 613K 301K 705K
    Shares Outstanding (Basic)
    		 19.7M 12.96M 12.24M 10.89M
    Shares Outstanding (Diluted)
    		 19.7M 12.96M 12.24M 10.89M
    EPS (Basic)
    		 -1.26 -2.96 -3.63 -8.41
    EPS (Diluted)
    		 -1.26 -2.96 -3.63 -8.41
    EBITDA
    		 -18.7M -34.58M -39.97M -83.2M
    EBIT
    		 -18.7M -36.33M -41.77M -85.31M
    Depreciation & Amortization
    		 284K 1.75M 1.8M 2.1M

    Add to Watchlist